Latest news
Kura Oncology Announces Blood Publication Detailing Discovery, Preclinical Characterization and Resistance Profile of Ziftomenib - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 12:47:00 GMTKura Oncology to Report Second Quarter 2026 Financial Results on August 12, 2026 - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:43:00 GMT